The customer reported that a patient had an anaphylactic reaction to the fresh frozen plasma(ffp) during a therapeutic plasma exchange (tpe) procedure.40 minutes into the procedure,the patient complained of shortness of breath and hives.The nurse disconnected the patient and the physician ordered iv benadryl in response to the patient reaction.Per the customer,the patient remained hospitalized following the event and is in stable condition.Customer declined to provide patient's identifier, age, and weight.The disposable kit is not available for return because it was discarded by the customer.This report is being filed due to medical intervention in the form of iv benadryl.
|
Investigation: the disposable set was unavailable for return and investigation.The customer did not provide the lot number pertaining to this event, therefore, a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.A service call was placed and the machine was inspected.The machine was verified to be working as designed.Root cause: the kit was unavailable for specific root cause.The machine was evaluated and determined to be functioning as intended.Based on the spectra optia system functioning as intended and the customer's evaluation of the issue, the reaction was due to the patient's physiology.Per the therapeutic apheresis handbook: a physician's reference, 2nd edition, plasma replacement reactions may occur in approximately 7.8% of procedures, based on the results of a survey of therapeutic procedures.Of these reactions, most were mild and well tolerated.The spectra system has many safety features.A patient reaction can occur rapidly, however, it is imperative that the operator continuously monitor the spectra system and the patient.The spectra essentials guide contains further cautions and warnings for the user.
|